Suppr超能文献

玻璃浸出物作为生物制药制剂中游离脂肪酸颗粒形成的成核因子。

Glass Leachables as a Nucleation Factor for Free Fatty Acid Particle Formation in Biopharmaceutical Formulations.

机构信息

Pharmaceutical Development & Supplies, Pharma Technical Development Biologics Europe, F. Hoffmann-La Roche, Grenzacherstr. 124, CH-4070 Basel.

Pharmaceutical Development & Supplies, Pharma Technical Development Biologics Europe, F. Hoffmann-La Roche, Grenzacherstr. 124, CH-4070 Basel.

出版信息

J Pharm Sci. 2021 Feb;110(2):785-795. doi: 10.1016/j.xphs.2020.09.050. Epub 2020 Oct 7.

Abstract

Surfactants are essential components in protein formulations protecting them against interfacial stress. One of the current industry-wide challenges is enzymatic degradation of parenteral surfactants such as polysorbate 20 (PS20) and polysorbate 80, which leads to the accumulation of free fatty acids (FFAs) potentially forming visible particles over the drug product shelf-life. While the concentration of FFAs can be quantified, the time point of particle formation remains unpredictable. In this work, we studied the influence of glass leachables as nucleation factors for FFA particle formation. We demonstrate the feasibility of nucleation of FFA particles in the presence of inorganic salts like NaAlO and CaCl simulating relevant glass leachables. We further demonstrate FFA particle formation depending on relevant aluminum concentrations. FFA particle formation was subsequently confirmed with lauric/myristic acid in the presence of different quantities and compositions of glass leachables obtained by several sterilization cycles using different types of glass vials. We further verified the formation of particles in aged protein formulation containing degraded PS20 through the spiking of glass leachables. Particles were characterized as a complex of glass leachables, such as aluminum and FFAs. Based on our findings, we propose a likely pathway for FFA particle formation that considers specific nucleation factors.

摘要

表面活性剂是蛋白质制剂的重要组成部分,可保护其免受界面压力的影响。目前行业面临的挑战之一是聚山梨酯 20(PS20)和聚山梨酯 80 等注射用表面活性剂的酶降解,这会导致游离脂肪酸(FFA)的积累,从而在药物产品的保质期内形成可见颗粒。虽然可以定量测定 FFA 的浓度,但颗粒形成的时间点仍然难以预测。在这项工作中,我们研究了玻璃浸出物作为 FFA 颗粒成核因素的影响。我们证明了在存在无机盐如 NaAlO 和 CaCl 的情况下,FFA 颗粒成核的可行性,模拟了相关的玻璃浸出物。我们进一步证明了 FFA 颗粒的形成取决于相关的铝浓度。随后,通过使用不同类型的玻璃瓶进行多次灭菌循环获得的几种玻璃浸出物的不同数量和组成,在存在不同数量和组成的玻璃浸出物的情况下,确认了 FFA 颗粒的形成。我们还通过添加玻璃浸出物验证了含有降解 PS20 的老化蛋白质制剂中颗粒的形成。这些颗粒被表征为玻璃浸出物(如铝和 FFA)的复合物。基于我们的发现,我们提出了一种可能的 FFA 颗粒形成途径,该途径考虑了特定的成核因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验